OmniInsight™ for Breast Cancer (OI-BC™) (PRS + Monogenic)

OmniInsight™ for Breast Cancer (OI-BC™) (PRS + Monogenic)

$1,900.00

OmniInsight™ for Breast Cancer (OI-BC™)

A Breakthrough Saliva Genetic Test for Predicting Breast Cancer Risk

OmniInsight™ for Breast Cancer is an advanced saliva-based genetic test that measures your inherited risk for breast cancer by analyzing both Polygenic Risk Scores (PRS) and Monogenic Mutations.
The test integrates clinically significant and actionable genes associated with breast cancer and combines them with a Multi-Ancestry Breast Cancer PRS, providing a comprehensive and precise risk estimate tailored to the individual being tested.

Results in 4–8 weeks

Test Highlights:

  • PRS Indication: Breast Cancer
  • Monogenic Genes: BRCA1, BRCA2, ATM, BARD1, CDH1, CHEK2, NF1, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53
  • Comprehensive Risk Report: Detailed interpretation of genetic findings and personalized prevention insights
  • Free Virtual Consultation: One-on-one session with a certified genetic counselor to explain your results and discuss next steps

Price Includes:
A complete Comprehensive Genomic Risk Test, including your personalized risk report, virtual counseling for individuals with above-average or high risk, and a customized prevention roadmap to support informed, proactive health decisions.

Exclusive Access:
Gain access to Avigena’s OmniInsight™ (OI™) Integrated Genomic Intelligence Platform, which combines Monogenic and Polygenic Risk Scores (PRS) with clinical and lifestyle data to deliver a holistic, personalized risk assessment and actionable prevention strategy.

Code: AVI-OI-BC™ Category:

"Prevent Breast Cancer."

Simple DNA Saliva Test To Uncover Your Inherited Risk For Breast Cancer

Validated across diverse ancestry and tailored to the Arab and Middle Eastern population

Breast Cancer Risk Management Sequence

What Is A Polygenic Score?

  • Everyone has small genetic differences, called variants.
  • These variants can affect the risk of developing certain diseases.
  • A polygenic risk score (PRS) combines the effects of millions of genetic variants to estimate your disease risk.
  • While each variant has a small effect, their combined impact can be significant.
Know More

Who Should Take This Test?

 Female – Adult (18-75 years)

Healthy women interested in understanding their personal risk of breast cancer.

Women diagnosed with breast cancer seeking to understand the genetic factors contributing to their disease.

Women who carry a rare monogenic mutation (e.g., BRCA) associated with increased breast cancer risk.

Women with a family history of breast cancer.

How It Works - Step By Step

Developed by Avigena (USA) and Novo Genomics (Saudi Arabia), and trusted by top U.S.
institutions, this test is tailored for Middle Eastern and Arab women.
Results are ready in 4 to 8 weeks, giving you time to act early and make informed decisions.

Order Now

Along with your personalized risk report, eligible patients receive a complimentary virtual
session with an Avigena genetic counselor. We’ll explain your results and help you explore
practical steps to reduce your risk.
Ask your doctor about the PRS for breast cancer—or contact us to learn more.
Your DNA can guide your prevention.

[email protected]